Nucleic acid aptamers to HIV-1 reverse transcriptase (RT) are potent inhibitors of DNA polymerase function in vitro, and they have been shown to inhibit viral replication when expressed in cultured T-lymphoid lines. We monitored RT inhibition by five RNA pseudoknot RNA aptamers in a series of biochemical assays designed to mimic discrete steps of viral reverse transcription. Our results demonstrate potent aptamer inhibition (IC 50 values in the low nM range) of all RT functions assayed, including RNA-and DNA-primed DNA polymerization, strand displacement synthesis, and polymerase-independent RNase H activity. Additionally, we observe differences in the time dependence of aptamer inhibition. Polymerase-independent RNase H activity is the most resistant to long-term aptamer suppression and RNA-dependent DNA polymerization is the most susceptible. Finally, when DNA polymerization was monitored in the presence of an RNA aptamer in combination with each of four different small molecule inhibitors, significant synergy was observed between the aptamer and the two NRTIs (AZTTP and ddCTP), while two NNRTIs showed either weak synergy (efavirenz) or antagonism (nevirapine). Together, these results support a model wherein aptamers suppress viral replication by cumulative inhibition of RT at every stage of genome replication.
strand in DNA/RNA heteroduplex replication intermediates. The enzyme is an asymmetric heterodimer composed of 66 kDa (p66) and 51 kDa (p51) subunits. The subunits associate initially as a p66 homodimer prior to removal of the C-terminus of one of the two subunits by the viral protease (1, 2) . The catalytic sites for both polymerase and RNase H function reside in the large subunit, while the small subunit contributes to primer/template binding and provides structural support for the large subunit (3, 4) . Its essential role in viral replication and the early availability of anti-RT drugs have made RT a featured target for clinical treatment of HIV infection. Eleven of the twenty FDA-approved anti-HIV compounds are RT inhibitors, which are themselves grouped into two classes -nucleoside analog RT inhibitors (NRTIs) and non-nucleoside analog RT inhibitors (NNRTIs) -based on their mode of action. The eight approved NRTI's are chain terminators that prevent the completion of viral genome replication following their incorporation by RT during DNA polymerization. The three NNRTIs, on the other hand, inhibit catalytic function directly by binding to RT near the polymerase active site and disrupting the local enzyme geometry (5) (6) (7) .
Administration of combinations of two NRTIs along with an NNRTI or protease inhibitor has proven to be an effective method of suppressing viral titers in HIV-1 patients (termed highly active antiviral therapy or HAART) (8, 9) . However, drug toxicity, adherence issues, and the emergence of multi-drug resistant strains necessitate the continued search for novel classes of HIV inhibitory compounds. Nucleic acid aptamers are one such class of molecules to have demonstrated significant antiviral efficacy in recent years (10, 11) . RNA and DNA aptamers generated by in vitro selections for binding to HIV-1 RT were first described as potent inhibitors of RT polymerase function over a decade ago (12) (13) (14) . Subsequent biochemical probing (15) and crystallographic studies (4) of a canonical RNA aptamer revealed a pseudoknot fold which binds to the enzyme at a site overlapping that of the primer/template substrate binding cleft. Wohrl and colleagues used an RNA aptamer in a trap assay to block multiple turnover of single nucleotide incorporation by HIV-1 RT (16) . Together, these observations led to introduction of the term "primer/template analog RT inhibitors" (TRTIs) to describe RTinhibiting aptamers as a class (17) .
It is important to establish the molecular basis for the antiviral action of nucleic acid aptamers. The most potent RNA aptamers inhibit polymerase function in vitro with IC 50 values in the low nanomolar range (12, 14) , and suppress viral replication when expressed in cultured lymphocytes (18) (19) (20) . PCR-based analysis of DNA extracted from aptamer-protected cells suggests that aptamers disrupt reverse transcription at one or more steps early in the process, as evidenced by the inability to detect viral genomic DNA beyond the formation of the minus strand strong stop product (19) . It is unclear whether viral escape from aptamer inhibition in these early stages would allow full replication, or if instead subsequent steps are similarly sensitive.
The process by which the HIV-1 RNA genome is copied to double-stranded DNA involves multiple steps requiring recognition of multiple different nucleic acid substrates and performance of two distinct enzymatic activities by the viral RT ( Figure 1A ). Kinetic analyses of primer-template recognition by RT (21, 22) have clearly demonstrated that the enzyme performs DNA synthesis much more efficiently from DNAprimed templates than from RNA-primed templates. Because RNA aptamers are competitive inhibitors of primer/template substrate binding by the enzyme, we reasoned that nucleic acid substrate composition should directly affect the enzyme's susceptibility to aptamer inhibition at different stages of genome replication. To better understand the point(s) at which RNA aptamers to RT most effectively inhibit HIV-1 reverse transcription, we performed a comprehensive biochemical analysis of RT inhibition by five RNA aptamers using in vitro assays that mimic various major steps of reverse transcription ( Figure 1A ). We demonstrate direct and potent inhibition of each RT function assayed, including RNase H activity. RNA-primed DNA polymerization is especially susceptible to aptamer inhibition to a degree not previously appreciated, as is distributive synthesis on both RNA and DNA templates. Our results suggest that the differential susceptibility of RT to aptamer inhibition is a direct function of primer-template backbone composition and enzymatic efficiency in accordance with previously established kinetic parameters. Furthermore, we propose that the multi-step nature of HIV-1 reverse transcription enhances the susceptibility of RT to aptamer TRTIs because of the many binding and dissociation events required for completion of genome replication. Finally, we tested an aptamer in combination with two NNRTI's and two NRTIs, and found that combinations that included the aptamer and an NRTI (AZTTP or ddCTP) display significant synergy for the inhibition of DNA polymerization by HIV-1 RT.
EXPERIMENTAL PROCEDURES
Reverse Transcriptase Cloning, Expression, and Purification -DNA fragments encoding the large (p66) and small (p51) subunits of HIV-1 strain HXB2 reverse transcriptase were amplified by PCR from plasmid pHIV-gpt (23) (obtained from the NIH ARRRP) and inserted into pET-200/D-TOPO expression vector (Invitrogen) according to the manufacturer's instructions and used to transform Escherichia coli strain BL21 Star™(DE3) (Invitrogen). p66-and p51-expressing bacterial lines were grown separately in 500mL Luria Broth supplemented with 50µg/mL kanamycin in a shaking incubator at 37°C. Protein expression was induced with 0.5 mM IPTG for 2-3 hours once the cells reached an OD 600 of 0.4-0.6. Cells were harvested and pellets were stored at -80°C for one to several days before purification. Frozen cell pellets containing expressed p66 and p51 subunits were thawed and resuspended together in a total of 40mL of ice cold 10mM imidazole, 500mM NaCl, 40mM MgCl 2 , 20mM NaH 2 PO 4 pH 7.4, 5% glycerol. The combined slurry was sonicated on ice to disrupt cell membranes and to release the soluble RT protein, and centrifuged 30 minutes at 14,000 rpm (Beckman JA-17 rotor) to pellet insoluble cell debris. Clarified lysate was passed over a Ni-NTA agarose column (Qiagen), washed with 150-200mL wash buffer (20mM imidazole, 500mM NaCl, 20mM NaH 2 PO 4 pH 7.4, 0.01% Triton X-100), and eluted with 10mL elution buffer (500mM imidazole, 500mM NaCl, 20mM NaH 2 PO 4 pH 7.4). Imidazole-eluted RT was further purified on a Sephadex G-100 Superfine gel filtration column equilibrated with wash buffer, and the recovered RT was concentrated on a second Ni-NTA column as described above. RT recovered from the second Ni-NTA column (6-8mL) was dialyzed against a 1L solution of 400mM NaCl, 32mM NaH 2 PO 4 pH 7.4, 20% glycerol, and 0.016% Triton X-100 at 4°C once overnight and again for 24hr with one change of buffer. Following dialysis, 0.6 volumes 100% glycerol was added to the recovered sample to bring the final glycerol concentration to 50%. Enzyme aliquots were stored at -20°C. Absorbance at 280 nm was used to determine the final protein concentration using a molar absorbance value of 263010 M -1 cm -1 . This value corresponds to the recombinant heterodimer including N-terminal fusion tags, and was calculated as described (24) , essentially by summing contributions to ε 280 from tryptophan, tyrosine, and half cystine residues.
RNA Aptamers -RNA aptamers 70.5, 70.8, 80.55 and 80.93 were previously identified by in vitro selection from random pools (14) . RNA for these four aptamers was generated by in vitro transcription from PCR templates using recombinant T7 RNA polymerase and purified on denaturing polyacrylamide gels. 70. Figure 1B) . Aptamer T1.1 (5'-GGGAGAUUCCGUUUUCAGUCGGGAAAAA CUGAA-3') is derived from an earlier in vitro selection for RT aptamers (12) . The RNA sequence used here is identical to the variant used previously for co-crystallization with HIV-1 RT (4).
General Methods for Assessing Aptamer
Inhibition of Reverse Transcriptase Activities -For each of the assays described below, RTincorporated Cy3-labeled dCTP (Amersham) or 5' Cy3-labeled DNA or RNA primers/oligos (Integrated DNA Technologies) were used to monitor RT enzymatic function. Each reaction was carried out in reaction buffer containing 75mM KCl, 5mM MgCl 2 , 50mM Tris-HCl pH 8.3, 10mM DTT, and 100ng/µl BSA. Purified RT was used at a final concentration of 3 nM in all assays unless otherwise noted. Reaction times varied from three to ten minutes depending on the rate of product formation in the absence of inhibitor; in general, reactions were allowed to proceed until maximum product formation was reached within the linear phase of the reaction (see Figure 6A ), as this allowed for maximal dynamic range for assessing inhibition. Reactions were quenched at the specified time with two volumes of 95% formamide, 50mM EDTA, and then heated for 2 minutes at 90°C prior to electrophoresis on denaturing polyacrylamide gels. Gels were scanned for fluorescence using a Fujifilm FLA5000 imaging system, and RT activity data were collected using Fujifilm Multi Gauge V2.3 image analysis software. IC 50 values for aptamer inhibition were obtained by fitting data to a sigmoidal dose response curve with GraphPad Prism software using equation (1);
Where Y is the measured fraction product formation at a given inhibitor concentration, and X is the log of the inhibitor concentration. All enzyme activity inhibition assays from which IC 50 values were calculated were performed in triplicate. Data was also fit to the quadratic equation (2) to better reflect the similar aptamer and RT stoichiometries of the inhibition reactions;
Y is the measured fraction product formation at a given inhibitor concentration (A), and B is the RT concentration for the experiment. Curves fit using both of the above equations yielded 50% maximal inhibition (IC 50 ) at identical locations on the X axis.
DNA-primed DNA-and RNA-Dependent DNA Polymerase Assays -An 18nt DNA primer corresponding to the tRNA lys,3 primer sequence (5'-Cy3-GTCCCTGTTCGGGCGCCA-3') was extended by a single nucleotide (ddCTP) on either a synthetic DNA or RNA 40nt template corresponding to the HXB2 PBS sequence (DNA version of the template: 5'-CAGTGTGGAAAATCTCTAGCAGTGGCGCC CGAACAGGGAC-3', nucleotides complementary to primer are underlined). Master mixes for 50 reactions were assembled by combining 30nM primer, 45nM template and 0.02mM ddCTP in reaction buffer, heated at 90°C for 90sec, and cooled at room temperature for 10 minutes to anneal the primer/template. 5µL aliquots were distributed into individual reaction tubes. 1µL of serially diluted aptamer in reaction buffer was added to each reaction tube to yield final aptamer concentrations of 0, 0.3, 1, 3, 10, 30, or 100nM. Reactions were initiated by the addition of 4µL RT, and incubated at 37°C for 3 minutes. Reactions were quenched and analyzed as described above. In a head to head comparison, we observe identical rates of product formation for reactions with dCTP and ddCTP (Supplemental Figure 1B) .
RNA-primed RNA-Dependent DNA Polymerase Assay -RNA-primed reactions from an RNA template were prepared and carried out essentially as the DNA-primed reactions except that dCTP (instead of ddCTP) was used at 5 mM, and the primer, template and RT were used at 300, 450 and 30nM, respectively, to account for the reduced affinity for RNA-primed complexes (22) .
RNA-primed DNA-Dependent DNA Polymerase Assay -The 18nt RNA primer (without Cy3 label) used in the RNA-primed RNA-dependent DNA polymerase assay was extended to completion on the 40nt DNA template used in the DNA-primed DNA-dependent DNA polymerase assay. Reactions were assembled by mixing 300nM primer, 450nM template, 0.1mM dATP, dGTP, dTTP, dCPT, and 0.02mM Cy3-dCTP (Amersham) in reaction buffer. Individual reaction aliquots (including aptamer) were prepared as described above. Reactions were quenched after 8 minutes at 37°C, and full-length product formation was monitored according to incorporation of Cy3-labeled deoxycytidine.
Distributive and Strand Displacement DNA Synthesis Assays -The 5'-Cy3-labeled 18nt DNA primer used in the DNA-primed DNA polymerase assays described above was extended to completion on either a 103nt DNA template corresponding to the HXB2 5' LTR (long terminal repeat) U5 and PBS sequences (5'-AAGTAGTGTGTGCCCGTCTGTTGTGTGACT CTGGTAACTAGAGATCCCTCAGACCCTTTT AGTCAGTGTGGAAAATCTCTAGCAGTGGC GCCCGAACAGGGAC-3') or a 106nt RNA template of identical sequence (generated by in vitro transcription using T7 RNA polymerase) with three appended 5' guanosines which were added to the RNA sequence for efficient in vitro transcription.
The DNA-dependent DNA polymerase assay was also performed in the presence of a 70nt blocking DNA oligo (BO) (5'-CACACTGACTAAAAGGGTCTGAGGGATCT CTAGTTACCAGACTCACACAACAGACGGG CACACACTACTT-3') complementary to the 5' 70nt of the template strand (underlined) to monitor strand displacement DNA synthesis. Reactions were assembled and initiated as described for the DNA-primed DNA polymerase assays above (0.02mM dNTPs instead of ddCTP), and incubated at 37°C for 10 minutes before quenching and electrophoresis.
Titration with varying concentrations of BO shows the 60 µM BO to be essentially saturating. DNA-dependent DNA polymerization in the absence of BO proceeded to completion more rapidly than did strand displacement; these assays were quenched after 3 minutes at 37°C.
Polymerase-Independent RNase H Activity Assay -A 43nt, fluorescently-labeled RNA oligo corresponding to the 5' end of the HXB2 RNA genome (5'-Cy3-GGUCUCUCUGGUUAGACCAGAUCUGAGC CUGGGAGCUCUCUGG-3') was subjected to RNase H cleavage by RT when annealed to a DNA oligo complementary to the 5' 53nt of the HXB2 genomic RNA (5'-CCCTAGTTAGCCAGAGAGCTCCCAGGCTC AGATCTGGTCTAACCAGAGAGACC-3'). Reactions were assembled by mixing 30nM RNA and 60nM DNA complement in reaction buffer, and individual reaction aliquots (including aptamer) were prepared as described above. Reactions were initiated by the addition of 4µL RT, incubated at 37°C for 3 minutes, and quenched and analyzed as described for the above assays.
Aptamer Inhibition Time Courses -A thirty minute time course for each of the above RT activity assays was performed in the absence or presence (10 or 30nM) of aptamer T1.1. All assays were prepared using the conditions described above, but scaled up to an 80µL final volume, from which 10µL aliquots were removed into 20µL of quench solution at the indicated time points. Data collection was performed for each assay as described above. Curves were fit with GraphPad Prism software using equation (3);
Y is product formation over time (t), which proceeds to a defined maximum (Y max ) with a rate constant (k).
Aptamer/Small Molecule Synergy Assays -The 5'-Cy3-labeled 18nt DNA primer described above was extended to completion on the 103nt DNA template in the presence of increasing concentrations of nevirapine (NVP), efavirenz (EFV), azidothymidine triphosphate (AZTTP), or dideoxycytidine triphosphate (ddCTP) using the reaction conditions described above for distributive synthesis. Final RT concentration for these assays was increased from 3nM to 10nM to boost signal. Inhibition was monitored using increasing concentrations of aptamer T1.1 in combination with the small molecule inhibitor at 100-fold excess (for NVP, AZTTP, or ddCTP) or 10-fold excess (EFV) over aptamer. IC 50 values obtained from combined aptamer/small molecule inhibition assays, and from each individual inhibitor were inserted into the Berenbaum (25) equation (4) to calculate an interaction index (I 50 ) value;
Where D (1) and D (2) are the IC 50 values for the two inhibitors when assayed in combination, and D 50 (1) and D 50 (2) are the IC 50 values for each inhibitor when assayed individually.
RESULTS

RNA Aptamer Inhibition of Reverse Transcriptase at Discrete Steps of Viral Genome
Replication -RT inhibition was measured in eight assays representative of discrete major functions performed by RT during viral genome replication ( Figure 1A ). To ensure that comparisons of IC 50 values across the eight assays are meaningful, and to avoid sequence-specific effects that might skew the analysis, all DNA polymerization experiments employed a primer sequence corresponding to the 3' 18nt of the host cell tRNA Lys3 that primes viral genome replication during viral infection and a template sequence corresponding to the viral genome sequence immediately 5' of the primer binding sequence (PBS) ( Figure 1A ). Likewise, all assays were performed using identical RT, primertemplate, and dNTP concentrations (unless noted), and for similar lengths of time such that in each case product formation was confined to the linear phase. To ascertain the generality of the results, five different RNA aptamers ( Figure 1B) were tested individually for RT inhibition in each assay. Two aptamers (70.5 and T1.1) conform to the sequence constraints that define the Family 1 (Tuerk-type) pseudoknots, and the other three (70.8, 80.55, and 80.93) form related but structurally distinct pseudoknots (12, 14, 15) .
DNA-and RNA-Primed Single Nucleotide Incorporation Assays -Over the course of genome replication, HIV-1 RT catalyzes both RNAdependent DNA polymerization (RDDP) and DNA-dependent DNA polymerization (DDDP), extending from both RNA primers (-rp) and DNA primers (-dp). Half-maximal inhibition (IC 50 ) of single nucleotide incorporation by RT in DDDPdp and RDDP-dp reactions occurs at low nanomolar concentrations (5-43nM) for each of the five aptamers (Figure 2A and 2B, and Table  1) , consistent with values obtained from earlier studies performed with this class of RNA pseudoknots (12, 14, 19) . Aptamer 80.93 gave roughly two-fold weaker inhibition (higher IC 50 ) relative to the other four aptamers in this assay and in most of the subsequent assays.
As discussed below, RNA-primed reactions are less efficient than DNA-primed reactions. We performed single nucleotide incorporation by RT in RDDP-rp reactions to determine whether DNA polymerization from RNA-primed substrates is more sensitive to inhibition than is extension from DNA-primed substrates ( Figure 2C ). Product formation was not detectable under the same assay conditions used for the DNA-primed substrates (3nM RT, 30nM primer, 45nM template, 0.02mM ddCTP). Therefore, these assays were performed at ten-fold higher RT and primer-template concentrations (30nM RT, 300nM primer, 450nM template), and 250-fold higher nucleotide triphosphate (5mM dCTP) concentration. Even under these conditions, net product formation in the absence of inhibitor was less efficient than product formation in the DDDP-dp reactions above. Despite these increases in substrate and enzyme concentrations, the observed IC 50 values for aptamer inhibition of single nucleotide incorporation in RDDP-rp reactions remained comparable to those observed for inhibition of extension from the two DNA-primed substrates ( Figure 2 , Table 1 ). To enable direct comparison of IC 50 values for the RNA-primed and DNAprimed reactions, single nucleotide incorporation by RT in DDDP-dp reactions was performed at the same high concentrations utilized in the RDDP-rp reaction. Under these conditions, the aptamers were only mildly inhibitory at the highest concentration tested (100nM) ( Figure 2D ). These results illustrate the higher sensitivity of RT to inhibition by aptamers during DNA polymerization from RNA-primed substrates.
RNA-Primed DNA Polymerization on a DNA Template -The three polymerase activity assays described above used a 5'-end labeled primer to monitor RT-catalyzed incorporation of a single nucleotide from each of three possible primertemplate substrates (DDDP-dp, RDDP-dp, and RDDP-rp). This assay design proved untenable for RDDP-dp reactions due to RNase H-catalyzed cleavage of the 5'-end labeled RNA/DNA heteroduplex two nucleotides from the 3' end of the labeled RNA strand. Note that RNase Hmediated primer removal requires binding of the RT in the opposite orientation, with the 3'-end of the DNA template positioned in the polymerase active site as if it were the primer, and the RNA oligo bound as the template strand. To monitor inhibition of DDDP-rp activity, we altered the assay design to detect Cy3-dCTP incorporation during full extension of the 40nt DNA template (Figure 3) . IC 50 values for inhibition of DDDP-rp activity by the five aptamers ranged from 45nM to 7 146nM, with aptamers T1.1, 80.55, and 70.5 being the most potent of the five. Overall the IC 50 values obtained for full extension of the 40nt DNA template from the RNA primer were on average three-to seven-fold higher than those for either of the DNA-primed single nucleotide incorporation assays (Table 1) , likely owing to changes in substrate affinity upon partial extension (see Discussion).
RNA-Dependent DNA PolymerizationInhibition by RNA aptamers of DNA polymerization from an RNA template (106 nt) was monitored by full extension of a DNA primer ( Figure 4A ). Aptamers T1.1, 70.5, 70.8, and 80.55 inhibited this activity with IC 50 values ranging from 3 to 5nM (Table 1 ). Aptamer 80.93 was roughly three-fold less potent, consistent with it being the least potent of the five aptamers across all activities assayed.
Overall, true reverse transcription (RNA-dependent DNA polymerization) was among the activities most potently inhibited by RNA aptamers described in this report (Table 1 and Figure 6 ).
DNA-Dependent DNA Polymerization and Strand Displacement Synthesis -To complete the synthesis of full-length genomic cDNA, HIV-1 RT must displace approximately 637 nucleotides of double-stranded DNA as it copies the LTR (26) (Figure 1, step 6 ). Previous biochemical analysis of strand displacement synthesis revealed a roughly twelve-fold reduction in polymerization rate and a decrease in RT processivity in the presence of a downstream duplex region several hundred nucleotides in length (27) . To determine whether RT is more susceptible to aptamer inhibition during strand displacement synthesis, RT was challenged with aptamers during DDDPdp reaction polymerization on a 103nt template in the absence and presence of a 70nt blocking oligo (BO, Figure 4B and 4C, respectively). Strand displacement synthesis (SDS) assays were allowed to proceed for ten minutes in the presence of BO, or three minutes in the absence of BO, to generate sufficient full-length product for reliable quantification of aptamer inhibition. In the presence of BO, extensive premature termination is evident immediately after the duplex is encountered, reducing yield to 15-20% of that observed without BO. Only weak pauses are observed after RT has extended through ~20 bp of duplex. In the absence of BO, premature termination is evident in the first several nucleotides synthesized, with an additional pause after a run of adenosines in the template immediately prior to the BO binding site. Product yields from both reactions were inhibited by all five aptamers. Interestingly, the aptamer dose response and the calculated IC 50 values for normalized product formation were essentially identical for DNA synthesis in both the presence and absence of BO ( Figure 4C and Table 1) . Similar results were obtained using a 103nt BO complementary to all but the primer binding site (not shown).
Polymerase-Independent RNase H ActivityRemoval of the RNA strand of the RNA/DNA heteroduplex replication intermediate by HIV-1 RNase H can occur either concurrent with, or uncoupled from DNA polymerization (28, 29) . By either route, RNase H substrate binding is functionally synonymous with primer-template binding, and should therefore be subject to aptamer competition. Inhibition of polymeraseindependent RNase H activity was monitored by incubating RT with a 5'-Cy3-labeled 43nt RNA strand annealed to a 53nt DNA in the absence of dNTPs ( Figure 5 ). The low nM IC 50 values obtained for this assay (10-28nM) are similar to the IC 50 values measured for the six previously described DNA polymerase activity assays ( Table  1 ), suggesting that these aptamers compete for RNase H substrate recognition to a degree comparable to that with which they compete with primer-template complexes.
Time-Dependence of Aptamer Potency -The IC 50 values listed in Table 1 are derived from aptamer inhibition assays with reaction times ranging from 3 to 10 minutes, as these time spans fall within the linear phase of product formation for each RT activity. Because these reaction times are brief relative to viral replication timescales, it is important to establish how well the inhibition observed in these assays translates into long-term potency of these aptamers over sustained time periods. Therefore, the eight RT activity assays described above were performed in the absence of aptamer, or in the presence of aptamer T1.1 at two concentrations near the observed IC 50 values (10 or 30nM) ( Figure 6 ). To determine the aptamer's ability to sustain an inhibitory effect, product formation was measured as a function of time and normalized within each assay to the product yield obtained at 30 minutes in the "no aptamer" control. In the absence of aptamer, the eight assays partitioned into three groups according to rates of product formation ( Figure 6 ). RNase H activity and single nucleotide incorporation in DDDP-dp reactions were completed most rapidly, DDDP-dp on the 103nt template, strand displacement, and single nucleotide incorporation in RDDP-dp reactions formed a second group of less-rapidly completed activities, and DDDP-rp, RDDP-rp, and RDDP-dp on the 106nt RNA template grouped as the least-rapidly completed activities. When 10nM aptamer was included in the reactions, RDDP-dp on the 106nt template was potently inhibited, reaching less than 15% full-length product formation in 30 minutes. When the aptamer concentration was raised to 30nM, only RNaseH activity and single nucleotide incorporation in DDDP-dp reactions proceeded beyond 50% completion by experiment's end. In contrast, single nucleotide incorporation in RDDP-dp and RDDP-rp reactions, and full extension of the long templates (RDDP-dp 106, DDDP-dp 103, and strand displacement synthesis) were severely inhibited (≤25% product formation) by 30nM aptamer over the entire 30 minutes. Note that the two RNA-primed DNA polymerization assays were potently inhibited by 30nM T1.1 despite the fact that these two assays included 10-fold higher RT and primer-template concentrations than those utilized in the other five assays. These results highlight the sensitivity of these RNA-primed steps to aptamer inhibition.
Aptamer Synergy with Small Molecule Reverse Transcriptase Inhibitors -Small molecule RT inhibitors administered in combination have been used to demonstrate synergy in both biochemical and cell-based assays (30) (31) (32) (33) (34) . Because RNA aptamer TRTIs bind to RT at a location that is distinct from the binding sites of either NNRTI or NRTI inhibitors, it is not obvious that there should be any interaction between aptamers and the small molecule RT inhibitors. To address the possibility of such functional interactions directly, DDDP-dp reactions on the 103nt template were monitored in the presence of aptamer in combination with NNRTI or NRTI inhibitors. IC 50 values were determined separately for aptamer T1.1, for two NRTI drugs (azidothymidine triphosphate (AZTTP) and dideoxycytosine triphosphate (ddCTP)), and for two NNRTI drugs (efavirenz (EFV) and nevirapine (NVP)) ( Table 2 ). The IC 50 value obtained for EFV (60nM) was approximately 20-fold lower than the IC 50 s obtained for the other three drugs (1.29 to 2.24 µM). Inhibition was then measured for serial dilutions of mixtures of these inhibitors at fixed 1:100 aptamer:small molecule ratios (1:10 for EFV). IC 50 values obtained from these assays were used to calculate the interaction index for 50% inhibition of enzyme activity (I 50 ), which is equal to 1 when two inhibitors are strictly additive (no interaction), less than 1 when the two inhibitors augment each other's potency (synergy), and greater than 1 when the two inhibitors interfere with each other's mode of action (antagonism). The two combinations of aptamer + NRTI both demonstrate clear synergy in inhibiting DNA polymerization (I AZTTP = 0.52; I ddCTP = 0.51). The combination of aptamer + EFV is either additive/non-interacting or slightly synergistic (I EFV = 0.91) for inhibition of DNA polymerization by RT. In contrast, the combination of aptamer + NVP appears to antagonize net inhibition (I NVP = 1.57). Thus, contrary to expectation, pseudoknot RNA aptamers and small molecule RT inhibitors clearly affect one another's capacity for enzyme inhibition. Potential mechanistic interpretations and clinical implications of these results are discussed below.
DISCUSSION
Differential Susceptibility of HIV-1 RT to Aptamer Inhibition at Different Stages of Genome
Replication -Nucleic acid aptamer inhibitors have therapeutic potential as a TRTI class of anti-viral agents. To develop a better understanding of the mode of viral inhibition by anti-RT RNA aptamers, this work separately evaluates RT enzymatic inhibition in reactions that mimic major activities required for completion of HIV-1 genome replication. Anti-RT aptamers inhibit polymerase and RNase H functions via competitive inhibition with primer-template, as demonstrated by comparative binding studies (13, 14) , pre-steady-state kinetic analysis (16) , and extensive overlap between the aptamer binding site and the primer-template binding site in a lowresolution co-crystal structure of RT in complex with RNA aptamer T1.1 (4). We provide further biochemical evidence for this model both here (Figure 2A vs. 2D) and in a separate work (Kissel et al., in preparation) by demonstrating that the relative concentrations of aptamer and primertemplate quantitatively affect RT inhibition. Similar competitive inhibition of DNA polymerization has been demonstrated for RNA aptamers selected to bind RT from feline immunodeficiency virus (35) . Aptamer TRTIs can therefore be expected to inhibit every step of reverse transcription during viral infection. Furthermore, because primer-template recognition (and therefore polymerase activity) varies according to nucleic acid composition, the potency of aptamer inhibition might also be expected to vary over the course of genome replication. Indeed, the results presented here suggest that every stage of replication is subject to aptamer inhibition, with the RNA-primed events being the most sensitive when considered on a pernucleotide-incorporation basis. RNA-templated DNA polymerization is the most sensitive to prolonged aptamer inhibition.
Direct comparisons of IC 50 values from one assay to another can be misleading unless the details of the individual assays are considered. For example, a cursory examination of Table 1 would suggest that the two RNA-primed events are the least sensitive to aptamer inhibition (highest IC 50 values), rather than the most sensitive. However, we were only able to observe reliable single nucleotide product formation during the RDDP-rp assay upon a ten-fold increase in enzyme and primer-template concentrations relative to those used for the DNA-primed DNA polymerization assays (along with a 250-fold increase in dNTP concentration). These conditions should greatly increase the ability of primer-template to compete with the aptamer. For example, when similar high concentrations of RT, primer-template and dNTP were used to monitor single nucleotide incorporation in DDDP-dp reactions, little inhibition is evident even at 100 nM aptamer ( Figure 2D ). Because K d values for RT binding to both RNA aptamers (12, 14) and the DNAprimer/DNA-template substrate (22, (36) (37) (38) are both in the low nM range, the 100 nM aptamer dose is unable to effectively prevent the 30nM RT from extending most of the 300 nM primertemplate in this experiment. In contrast, the fact that the observed IC 50 values for both of the RNAprimed reactions (DDDP-rp and RDDP-rp) are in the same range as the other values in Table 1 suggests that aptamer inhibition of DNA polymerization from RNA-primed templates is significantly more potent than polymerization from DNA-primed templates.
Our results can be generally understood in terms of the enzyme's reduced efficiency on RNAprimed templates. Pre-steady-state kinetic analyses of single nucleotide incorporation clearly reveal less efficient DNA polymerization from RNAprimed substrates than from DNA-primed substrates, irrespective of whether DNA or RNA templates were utilized. Affinity for the primertemplate (K m p/t ) is ~200-fold weaker, affinity for dNTP (K m dNTP ) is ~500-fold weaker, and the rate of polymerization (k cat ) is ~30-fold slower (21, 22) . This overall difference in enzyme efficiency persists for roughly the first six dNTP incorporations, by which point the polymerization properties become indistinguishable from those associated with DNA-primed templates. Thus, once an RNA primer is extended by a few nucleotides, its susceptibility to inhibition converts to that of a DNA-primed reaction. The step-wise transformation of a low-affinity to a high-affinity ternary complex likely accounts for the higher observed IC 50 for the DDDP-rp primer extension assay relative to the single-nucleotide incorporation assay used for the RDDP-rp reaction. In the context of viral replication, the quantitative aspects of this interpretation may require slight refinement, depending on the degree to which the natural RNA primers (tRNA Lys3 and PPT (polypurine tract)) used by the virus during infection are similarly displaced by the aptamers.
Sustained Inhibition of RNase H and DNA Polymerization by RNA Aptamers -Our results demonstrate for the first time the direct inhibition of polymerization-independent RNase H activity by pseudoknot RNA aptamers to HIV-1 RT. Other labs have described RNase H inhibition by DNA aptamers and thioaptamers selected specifically to bind the RNase H domain of HIV-1 RT (39-41), and RNA aptamer inhibition of the RNase H activity of RTs derived from avian myeloblastosis virus and Moloney murine leukemia virus by aptamers specifically targeted to these RTs (42) . Interestingly, although the half-maximal inhibition of RNase H activity in the present study occurred at aptamer concentrations similar to those required to inhibit most of the other RT activities (Table 1 ), the time scale over which aptamers remain potent against RNase H was very brief (Figure 6 ). A possible explanation for this phenomenon derives from the fact that the readout for RNA strand cleavage corresponds to loss of full-length RNA substrate that can result from a single binding/catalytic event. Thus, if aptamer fails to prevent substrate binding, the RNase H cleavage reaction proceeds immediately to completion. This circumstance is in sharp contrast to the four true DNA polymerization assays (DDDP-dp 103, strand displacement, RDDP-dp 106, and DDDPrp), where product formation readout corresponds to full copying of the template strand, which may require multiple primer-template substrate rebinding events before RT completes a full-length strand extension. In these assays, unlike the RNase H activity assay, any substrate release by RT prior to complete strand extension offers the aptamer a second opportunity to bind and inhibit free RT.
Single nucleotide incorporation in DDDP-dp reactions is similarly resistant to aptamer inhibition over time, again resulting from product formation after a single binding/catalytic event. The RDDP-dp and RDDP-rp single nucleotide incorporation assays show greater susceptibility to sustained aptamer inhibition. The potency of inhibition during the RDDP-rp assay (again performed at 10-fold increased enzyme and primer-template, and 250-fold increased dNTP concentrations relative to the DDDP assays) is enhanced by the enzyme's diminished affinity for this substrate relative to both aptamer and the DNA-primer/DNA-template substrate. In our hands, DNA polymerization (both single nucleotide incorporation and full copying of the 106nt template) on the RNA templates was consistently less efficient than on the DNA templates (left lanes Figures 2A and 2B , left lanes Figures 4 and 5A, and 7A ). This result is in contrast with previous reports of single nucleotide incorporation in RDDP-dp reactions with binding and polymerization kinetics either similar to (22) or slightly better than (16) those obtained in DDDP-dp reactions. Thus, the sustained inhibition of single nucleotide incorporation in the RDDP-dp reactions was somewhat more potent than anticipated.
Sustained potent inhibition of DNA polymerization by RNA aptamers is of key importance, as the majority of catalytic events performed by the enzyme during viral genome replication are consecutive dNTP incorporations on long templates. HIV-1 RT is a low processivity polymerase, with reports ranging from several tens to several hundreds of nucleotides polymerized per binding event (17, (43) (44) (45) (46) . The number of opportunities for aptamer binding and inhibition of RT during genome replication increases with the number of times the polymerase dissociates from the primer-template substrate. We therefore propose that the observed potent inhibition of primer extension over time is directly attributable to the semi-distributive nature of DNA polymerization by HIV-1 RT. This notion is consistent with the classification of RNA aptamers as TRTIs, which function in a manner analogous to a trapping nucleic acid (or other anionic polymer such as heparin) used in standard polymerase processivity assays.
Aptamer Synergy with Small Molecule Reverse Transcriptase Inhibitors -The decrease in AIDSrelated mortality over the last twenty years as antiviral treatment strategies shifted from monotherapy to potent three-drug HAART (47) reveals the importance of combinatorial approaches to inhibiting viral function. Therapeutic combinations targeting different viral proteins reduce the likelihood of selecting drug resistant viruses. Combining inhibitors from different classes that target the same viral protein not only offers protection against resistance, it also affords the possibility of enhanced inhibition via synergistic effects (30) (31) (32) (33) (34) . The two NNRTIs assayed here (NVP and EFV) have different effects on RT in the presence of aptamer T1.1 (Table 2 ). Aptamer T1.1 and NVP antagonize one another in a DDDP-dp inhibition assay, while T1.1 and EFV act additively or with weak synergy. In contrast, aptamer T1.1 and each of the two NRTIs tested (AZTTP and ddCTP) combine to exhibit a high degree of synergy for the inhibition of DNA polymerization by RT.
At least two models can explain our observations. In the first model, the presence of one compound may alter the other's ability to bind RT. Because aptamer binding prevents RT's association with primer-template, it seems unlikely that any of these small molecule drugs could directly inhibit the enzymatic activity of a given RT molecule as long as aptamer is bound; instead, small molecule binding may enhance (or in the case of NVP weaken) RT's affinity for the aptamer. This model is consistent with recent reports of a small molecule RNase H inhibitor that binds near the polymerization active site and that is believed to act by repositioning the RNA-DNA heteroduplex relative to the RNase H active site (Stefan G. Sarafianos, personal communication). It is also consistent with reports of NNRTI-resistant RTs which demonstrate diminished RNase H function (48, 49) . In the second model, we propose that the non-extendible primer-template substrates that form upon incorporation of either AZT or ddC effectively increase the net concentration of TRTI inhibitors. Specifically, both the aptamer and NRTI-capped primer-template can bind RT and compete with non-capped primer-template substrates with similar low nM binding affinities. Thus, the low-affinity, small-molecule inhibitor (chain-terminating NRTI) is transformed into a high-affinity inhibitor by the RT. The magnitude of this effect increases during the course of the assay as capped product accumulates. It is not clear whether synergy by this mechanism could operate during viral infection, where the number of NRTI-capped products generated will be limited. Even so, a therapeutic strategy combining anti-RT aptamers with NRTI drugs (and potentially EFV) could augment the antiviral potency of both drug types.
Significance for Antiviral Inhibition by RNA Aptamers -Joshi and Prasad monitored viral DNA synthesis in cells infected with virus in the presence of truncated versions of aptamers 70.8 and 70.15 (the latter aptamer was not evaluated here) (19) . Although they detected low levels of viral cDNA corresponding to minus-strand strong stop synthesis, they were unable to detect cDNA from later replication steps. We specifically monitored aptamer inhibition of steps leading up to minus-strand transfer, in addition to subsequent steps of reverse transcription to test whether early events are measurably more susceptible to aptamer inhibition than later genome replication events. Our results suggest that RNA-primed and RNAtemplated DNA polymerization events are inhibited by RNA aptamers with notable potency (Figure 6 ). RT becomes susceptible to aptamer TRTIs whenever it is not bound by primertemplate, a circumstance that certainly occurs during priming and distributive DNA polymerization. There are at least six de novo priming events during HIV-1 genome replication: initiation of minus strand synthesis, re-initiation following first strand transfer, initiation of plus strand synthesis (from both PPT and cPPT), reinitiation following second strand transfer, and initiation of strand displacement synthesis. Half of these are RNA-primed events. Thus, although RNA-primed DNA polymerization represents less than 0.1% of the total nucleotide incorporations performed by RT during genome replication, initiation of DNA synthesis from RNA primers may represent biologically substantial opportunities for aptamer inhibition. In addition, periodic dissociation of RT during DNA synthesis provides further opportunities for aptamer TRTIs to sequester free RT and disrupt genome replication. Therefore, despite the variability of aptamer potency summarized in Table 1 and Figure 6 , we propose that aptamer inhibition of RT function during viral infection is compounded over the many different steps required to convert the RNA genome to a double-stranded DNA copy. This cumulative inhibition appears to best explain the dramatic inhibition of viral replication previously observed in aptamer-expressing cultured T lymphocytes.
Finally, we observed a high degree of synergy for the inhibition of the DNA polymerization function of RT when an aptamer was used in combination with either ddCTP or AZTTP, suggesting that the combination of TRTIs and NRTIs may provide a new and potent approach for the continuing development of multi-pronged antiviral therapies. Figure 1 . HIV-1 genome replication, representative enzymatic assays, and RNA aptamers. (A) Viral genome replication steps are outlined to the left, with numbered enzyme activity assays that simulate different steps during genome replication shown to the right. RNA is shown in red, DNA is shown in blue, and newly-synthesized DNA is shown in cyan. Cy3-fluor is shown in green. (1) A host cell tRNA Lys3 anneals to the viral RNA PBS (primer binding sequence) to prime minus strand synthesis. DNA polymerization to the 5' end of the RNA genome template terminates in a strong stop. (2) RNase H degradation of the copied 5' end of the RNA genome by RT frees the strong stop DNA product for minus strand transfer. (3a and 3b) Strong stop DNA anneals to the 3' end of the viral RNA to prime DNA synthesis. RNase H degradation of the RNA genome during minus strand synthesis leaves behind an RNA polypurine tract fragment which primes plus strand synthesis (4) . (5a and 5b) Plus strand synthesis is templated by the minus strand DNA copy of the genome. Second strand transfer followed by strand displacement synthesis (6) allows complete extension of both DNA copies. (B) Five RNA aptamers that bind and inhibit HIV-1 reverse transcriptase. Aptamers are divided into two classes (14) based on structural similarity to the canonical T1.1 aptamer (12, 15) . The complete sequence of aptamer T1.1 is shown; for the other aptamers, only the portion of the sequence believed to form a pseudoknot structure and the immediately flanking nucleotides is shown (see the Materials and Methods section for the complete RNA sequences). Capital letters correspond to nucleotides derived from the random sequence region in the original pool, lower case letters correspond to nucleotides derived from invariant primerbinding sequences in the original pool. Figure 2 . Aptamer inhibition of single nucleotide incorporation by HIV-1 RT. DDDP-dp (A) and RDDP-dp (B) reactions in which primer/ template complexes (30nM/45nM) were extended by a single nucleotide (ddCTP, 0.02mM) for 3 minutes by RT (3nM) in the presence of 0.3-100nM RNA aptamers T1.1, 70.5, 70.8, 80.55, or 80.93. RDDP-rp (C) and DDDP-dp (D) reactions performed under otherwise identical conditions in which high concentrations of primer/template complexes (300nM/450nM p/t) were extended by a single nucleotide (5 mM dCTP, or 0.02mM ddCTP, respectively) for 3 minutes by RT (30nM) in the presence of 0.3-100nM the same five aptamers. Representative gel images (20% denaturing polyacrylamide) from each assay show no aptamer (first lane), increasing aptamer (middle six lanes), and no RT (last lane). Fraction product formation (single nucleotide incorporation) is normalized to the no aptamer control (1.0) for each experiment. .55, or 80.93 (A) in RDDP-dp reactions (30nM/180nM) for 10 minutes, (B) in DDDP-dp reactions (30nM/45nM) for 3 minutes, and (C) in DDDP-dp reactions (30nM/45nM) with a 70nt blocking oligo (BO) (60nM) annealed to the 5' 70nt of the template strand for 10 minutes. dNTP concentrations in all assays were 0.02mM. Representative gel images (15% denaturing polyacrylamide) from each assay show no aptamer (first lane), increasing aptamer (middle six lanes), and no RT (last lane). Vertical black bar (C) indicates location of annealed BO. Fraction product formation (full primer extension) is normalized to the no aptamer control (1.0) for each experiment. ddCTP Incorporation DDDP-dp ddCTP Incorporation RDDP-dp ddCTP Incorporation DDDP-dp (RDDP-rp Condititions) RDDP-dp (106 Temp) DDDP-dp RDDP-dp RDDP-rp DDDP-rp DDDP-dp 103 DDDP-dp SDS RNaseH RDDP-dp 106
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Time (min) % Product Formation Figure 6 A B C Table 1 . Aptamer Inhibition Totals * RDDP-rp and DDDP-rp reactions were performed using 10-fold greater RT, primer, and template, and 250-fold greater dNTP concentrations relative to the other five assays, yet IC 50 values are less than 10-fold increased, suggesting that these two assays are effectively at least 10-fold more sensitive to aptamer inhibition. * *
